Correlation Between Actinogen Medical and National Australia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Actinogen Medical and National Australia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Actinogen Medical and National Australia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Actinogen Medical and National Australia Bank, you can compare the effects of market volatilities on Actinogen Medical and National Australia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Actinogen Medical with a short position of National Australia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Actinogen Medical and National Australia.

Diversification Opportunities for Actinogen Medical and National Australia

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Actinogen and National is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Actinogen Medical and National Australia Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National Australia Bank and Actinogen Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Actinogen Medical are associated (or correlated) with National Australia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National Australia Bank has no effect on the direction of Actinogen Medical i.e., Actinogen Medical and National Australia go up and down completely randomly.

Pair Corralation between Actinogen Medical and National Australia

Assuming the 90 days trading horizon Actinogen Medical is expected to generate 32.2 times more return on investment than National Australia. However, Actinogen Medical is 32.2 times more volatile than National Australia Bank. It trades about 0.03 of its potential returns per unit of risk. National Australia Bank is currently generating about 0.09 per unit of risk. If you would invest  4.42  in Actinogen Medical on September 4, 2024 and sell it today you would lose (1.52) from holding Actinogen Medical or give up 34.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Actinogen Medical  vs.  National Australia Bank

 Performance 
       Timeline  
Actinogen Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Actinogen Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
National Australia Bank 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in National Australia Bank are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, National Australia is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Actinogen Medical and National Australia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Actinogen Medical and National Australia

The main advantage of trading using opposite Actinogen Medical and National Australia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Actinogen Medical position performs unexpectedly, National Australia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National Australia will offset losses from the drop in National Australia's long position.
The idea behind Actinogen Medical and National Australia Bank pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges